UBS Group
FRLN

UBS Group’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

UBS Group’s Portfolio FRLN Stock Details FRLN Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
2023
Q4 		$633K Buy
2023
Q3 		$147K Buy
2023
Q2 		$86K Hold
2023
Q1 		$228K Sell
2022
Q4 		$248K Buy
2022
Q3 		$361K Buy
2022
Q2 		$439K Sell
2022
Q1 		$565K Buy
2021
Q4 		– Sell
2021
Q3 		$2K Buy